Sort
82,697 grants matching “vaccine development”
Dendritic cells heterogeneity and function
$1,516,070Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Midwest Sexually Transmitted Infections Topical Microbicide Cooperative Research
$1,515,945Stanley M Spinola · Indiana Univ-Purdue Univ At Indianapolis · U19 · FY2007 · AI
University of Rochester HIV/AIDS Clinical Trials Unit
$1,515,664Michael C Keefer · University Of Rochester · UM1 · FY2020 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,515,427Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2025 · AI
Plant-Made Microbicides and Mucosal Vaccines for STIs
$1,515,292Arizona State University-Tempe Campus · U19 · FY2005 · AI
ESTABLISHMENT OF SPECIFIC PATHOGEN FREE RHESUS AND PIGTA
$1,515,234Oregon Health And Science University · U24 · FY2002 · RR
Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)
$1,514,714Donald Brambilla · Research Triangle Institute · U01 · FY2020 · AI
Task A05 Small animal model development for invasive aspergillosis
$1,514,576 · N01 · FY2010 · AI
UAB CENTER FOR AIDS RESEARCH
$1,514,523University Of Alabama At Birmingham · P30 · FY2001 · AI
Vector-borne pathogen transmission
$1,514,206Shaden Kamhawi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
DCP - COPTRG - SELECT/PCPT
$1,514,138Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2024 · CA
Adjuvant Development in the context of vaccines for Zika, Dengue and West Nile virus
$1,513,468Virovax Llc · N01 · FY2018 · AI
Development of an H2O2-Inactivated Dengue Virus Vaccine
$1,513,340Mark K Slifka · Oregon Health & Science University · R01 · FY2015 · AI
National AIDS Research Institute (NARI), Pune, INDIA: Clinical Trials Unit
$1,513,328Sanjay M Mehendale · National Aids Research Institute · U01 · FY2007 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,512,886Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2025 · AI
HIV/AIDS Clinical Trial Unit in NCAIDS, China CDC
$1,512,597Yiming Shao · National Center For Aids/Std Control And Prevention · U01 · FY2009 · AI
Antigen Processing And Presentation In The Intestine
$1,512,590Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Building a Systems Immunopeptidomics Framework to Challenge the Current T Cell Activation Paradigm
$1,512,500Etienne Caron · Yale University · DP2 · FY2025 · CA
A kit for massively parallel single cell gene expression analysis
$1,512,400Christina Fan · Cellular Research, Inc. · R44 · FY2015 · HG
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS
$1,512,195University Of Maryland Baltimore · U01 · FY2001 · HD
Adaptive Immunity and Persistent SARS-CoV-2 Replication
$1,512,103Suresh B Boppana · University Of Alabama At Birmingham · U01 · FY2023 · CA
Molecular Approaches To Antiviral and Vaccine Development For Viral Hepatitis and Other Viral Diseases
$1,512,099T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Cape Town Clinical Trials Unit (CT-CTU) for HIV/AIDS Prevention & Treatment
$1,511,717Robin Wood · University Of Cape Town · U01 · FY2008 · AI
Immunotherapeutic Approaches for AIDS
$1,511,661George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Stanford/UNC Biomimetic U19 Research Center
$1,511,551Calvin J Kuo · Stanford University · U19 · FY2022 · AI